Platinum resistant - Globe Thesis

Keyword [Platinum resistant] Result: 1 - 20 \| Page: 1 of 2
1.	By Annexin A3 Expression In Ovarian Cancer, Platinum-resistant Cell Lines And Ovarian Cancer Cells To Cisplatin-induced Apoptosis, In A Stable Culture
2.	Development Of Platinum-resistant Ovarian Cancer Marker Protein Annexin A3 Chemiluminescence Kit And Its Clinical Applications
3.	Screening And Identification Of The Differential Proteins And Genes Between Platinum-resistant And Platinum-sensitive Cells Of Human Ovarian Epithelial Cancer
4.	The Study Of Effects Of Parthenolide On Epithelial Ovarian Cancer Cell And Platinum-resistant Cell
5.	Study Of Interaction Of Protein Annexin A3and Protein TAp73in Platinum-resistant Ovarian Cancer Cell Line
6.	Studies Of The Effect And Mechanisms Of Triptolide On Platinum-resistant Ovarian Cancer Cell Line SKOV3/DDP In Vitro
7.	The Effect Of Î³-secretase Inhibitors On Chemosensitivity In Platinum-resistant Ovarian Cancer Cell Line
8.	Study Of Sensitivity And Related Mechanisms For Recombinant Human Adenovirus P53Combined With Cisplatin Acting On Platinum-resistant Human Ovarian Cancer Cells COC1/DDP
9.	The Effect Of Diclofenac On The Sensitivity To Chemotherapy Drug In Platinum-resistant Ovarian Cancer Cell Line COC1/DDP
10.	GnRH Analogues In Combination With Cisplatin Inhibited Platinum-resistant Ovarian Cancer Cell Invasion, Metastasis And Angiogenesis
11.	The Study On The Effect And Mechanism Of Curcumin On Chemosensitization Of Platinum-resistant Ovatian Cancer Cell Lines SKOV3/CDDP
12.	1 Nedaplatin And Paclitaxel Compared With Carboplatin And Paclitaxel For Patients With Platinum-Sensitive Recurrent Ovarian Cancer 2 Copy Number Variations Of Neurotrophic Tyrosine Receptor Kinase 3 (NTRK3) May Predict Prognosis Of Ovarian Cancer
13.	Analysis Of Factors Related To Recurrence Of Platinum Resistant Epithelial Ovarian Cancer
14.	Monitoring Of Platinum Chemotherapy Response In Epithelial Ovarian Carcinoma By Serum CA125 And HE4 Levels
15.	Chapter 2:Study On Expression Levels Of ITGB6,PIK3R3,NCALD,LAMA3 And Clinical Outcome In Platinum-resistant Ovarian Cancer
16.	Correlation Between Serum CA125 And Platinum Resistance Recurrence And Prognosis In Patients With Ovarian Cancer
17.	The Research Of Sall4 In Platinum-resistant Non-small Cell Lung Cancer
18.	Efficacy And Safety Of Apatinib In The Treatment Of Platinum-Resistant Ovarian Cancer
19.	Reversal Of Platinum-based Chemotherapy Resistance Related Molecules In Ovarian Cancer
20.	1 A Study Of Efficacy And Its Correlation With Plasma Biomarkers For Platinum-Resistant Recurrent Ovarian Cancer Patients Treated With PLD Combined With Apatinib Or PLD Alone 2 An Exploratory Analysis About Cycles Of Adjuvant Chemotherapy And Outcomes By
<<First <Prev Next> Last>> Jump to